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SUMMARY
Introduction The importance of vitamin D on bone health and osteoporosis was studied by many 
researchers. The main role of the Vitamin D is to absorb calcium and phosphate and increase bone 
mineralization. Older people are at an increased risk of the inadequate vitamin D production in the skin 
because of lower sun exposure and reduced ability of the skin to synthesize vitamin D.
Objective The aim of this clinical trial was to evaluate the efficacy and tolerability of short-term (2 weeks) 
low energy UVB irradiation in postmenopausal women with osteoporosis using bone mineral density 
and bone turnover markers.
Methods A three-month, single-blinded, randomized, placebo-controlled clinical trial was conducted 
at the University hospital in Daegu, Republic of Korea. Fifty-two postmenopausal Korean women (older 
than 65 years) with osteoporosis were randomly allocated to have either low energy UVB or placebo for 
30 minutes a day for two weeks of treatment during winter. Laboratory analysis and physical examination 
before and 4, 8 and 12 weeks after treatment were carried out and BMD was measured before and 8 and 
12 weeks after treatment. The effects of time and treatment interaction between these two groups were 
evaluated by repeated-measure two-factor analysis, and subgroup analysis was performed to examine 
UVB effect on the vitamin D insufficient group [serum 25(OH)D3 concentration <30 ng/mL].
Results In vitamin D insufficient group, the effect of UVB irradiation on vitamin D and bone ALP as well as 
additional benefit on bone formation was confirmed. The vitamin D insufficient group showed statistically 
significant increment in serum 25(OH)D3 compared with the normal group (p<0.05). However, there was 
no significant difference between two groups in the other bone turnover markers, such as serum calcium, 
PTH-C, serum osteocalcin, serum CTX and BMD.
Conclusion Low-energy-short-term UVB radiation for postmenopausal women may be of use in vitamin 
D synthesis. There was a modest benefit in change of bone ALP especially in women with the insufficient 
vitamin D.
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INTRODUCTION
Osteoporosis has emerged as an important 
metabolic bone disease globally. The percent-
age of elderly people over 65 years was 3.4 in 
1975, 6.8 in 2000 and will be 17% of the world’s 
population by 2050. Based on the population 
growth, the current incidence of osteoporosis-
related fractures in Asia became a significant 
public health burden [1].
The best treatment option for osteoporosis 
is prevention by increasing the maximal bone 
quantity before menopause to decrease the risk 
of fractures in postmenopausal women [2].
The importance of vitamin D on bone health 
was studied by many researchers. They suggest-
ed vitamin D as a hormone-like material which 
acts on bone, the intestines and parathyroid. 
The main role of the vitamin D is to absorb 
calcium and phosphate and increase bone min-
eralisation [3, 4].
Older people are at an increased risk of in-
adequate vitamin D production in the skin be-
cause of diminished sun exposure and reduced 
ability of the skin to synthesize vitamin D [5]. 
The resulting vitamin D insufficiency may have 
negative effects on maintenance of bone mass. 
There have been many studies showing that cal-
cium and vitamin D supplementation reduces 
bone loss and has beneficial effect on bone 
metabolism [6, 7]. Some researchers advocate 
additional effects of vitamin D in the presence 
of high calcium intake [8, 9].
Although the role of sun rays has been em-
phasized by many researchers [3-6], there have 
been few studies describing the role of ultravio-  
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let light in the elderly population with clinically confirmed 
osteoporosis in terms of bone mineral density and bone 
turn over biomarkers in the clinical setting [5, 6]. Further-
more, there are few data on relative effects of ultraviolet 
B (UVB) in the elderly osteoporotic patients with vitamin 
D insufficiency [10].
OBJECTIVE
The purpose of this study is to evaluate the efficacy and 
tolerability of short-term ultraviolet B(UVB) irradiation 
in the elderly osteoporotic Korean population. This report 
presents a single-blinded, randomized, placebo-controlled 
clinical trial of the effects of UVB irradiation on bone min-
eral density (BMD) and bone turnover markers in post-
menopausal women with osteoporosis.
METHODS
Study design
One hundred and ten ambulatory, late postmenopausal 
(>65 year) women were enrolled in the study. Subjects 
were excluded who had 1) a history of cancer within the 5 
years before the study, 2) a medical disease such as chronic 
renal failure or Cushing disease, or 3) any condition that 
might interfere with the evaluation of BMD (e.g., spinal 
fusion, treatment with systemic steroid, previous fracture 
of hips or spine). Any participant consuming vitamin D or 
calcium supplement was excluded. All participants were 
requested to have BMD study and confirmed osteoporosis 
based on World Health Organization (WHO) criteria (T-
score below -2.5).
We hypothesized that UVB radiation could affect 
bone formation. Therefore, bone alkaline phosphatase 
(ALP) became the primary endpoint in this study. For 
sample size determination, significance level(α)=0.05, 
power(1-β)=0.80 and mean difference of bone ALP be-
tween groups was 0.05, SD=0.06 [11] and 10% drop out 
rate were used. Each group consisted of 26 individuals.
All random codes were generated by the medical stat-
istician using the computer programme, which the other 
researchers involved in the study were not able to access. 
Fifty-two subjects were randomly assigned to receive either 
ultraviolet light lamp or placebo (florescent light lamp) 
(Scheme 1).
The study was approved by the Kyungpook National 
University Hospital IRB (Institutional Review Board). The 
informed consent was obtained from all participants before 
inclusion into the study.
Treatment
The experimental group was exposed to low energy UVB 
(Senia®, NB Tech, Korea) at wavelength between 280 and 
400 nm on the abdomen and the thigh for 30 minutes a 
day for 2 weeks. The control group was exposed to fluo-
rescent lamp in the same setting. The distance between 
the lamp and abdomen was 100 cm. The of the ultraviolet 
lamp was 4.0-5.0 μw/cm2 and it was 0.01 μw/cm2 for the 
fluorescent lamp. A serological examination was carried 
out before treatment and 4, 8, and 12 weeks after treat-
ment between 09 a.m. and 11 a.m. after overnight fasting to 
control the circadian rhythm. A radiological examination 
was performed before treatment and 8 and 12 weeks after 
treatment. All subjects took a calcium tablet daily (Mycal®, 
Myungmun, 1000 mg/day) without limitation of food in-
take or daily activities (for one month) for preventing bone 
loss during this study.
Biochemical bone markers
Fasting bone specific alkaline phosphate (Bone ALP) and 
osteocalcin (OC) were measured as bone formation mark-
ers. Fasting serum C-terminal telopeptide of type I col-
lagen (CTX) was measured as a bone absorption marker 
and 25 hydroxyvitamin D[25(OH)D3], serum calcium, 
C-terminal parathyroid hormone (PTH-C) and OC were 
measured as calcium metabolism markers.
Bone ALP was measured by Metra BAP ELISA® 
(QUIDEL, USA; ref 15-41.3 U/L). 25(OH)D3 was assessed 
by 25-OH-VitD3 Ria CT® (Biosource, Belgium; ref 7.6-75.0 
ng/mL). Serum OC was measured using N-MID osteocal-
cin ECLIA® (Roche Diagnostics, Swiss; ref 14-46 ng/mL). 
Plasma PTH levels were examined by EIKEN PTH RIA 
kit® (Eiken Chemical Co., Ltd, Japan; ref below 0.6 ng/ml) 
(the antibody recognizes the portion of PTH-C). Serum 
calcium was measured on Roche/Hitachi MODULAR 
System® (Roche Diagnostics, USA; ref 8.8-10.2 mg/dl).   
Serum CTX was determined by Elecsys β-Cross Laps im-
munoassay® (Roche Diagnostics, USA; ref 0.33–0.78 ng/ml).   
All serum concentrations were measured by regular labo-
ratory method.
110 women (>65 year)
– 58 excluded
– 52 included
52 randomised
26 allocated to control
group
[placebo+calcium]
– 24 included in analysis
– 2 incomplete data
   or voluntary drop-out
26 allocated to
experiment group
[UVB+calcim]
– 24 included in analysis
– 2 voluntary drop-out
– 8 Vitamin D 
insufficient
group
[25(OH)D≤30ng/mL]
– 16 Vitamin D normal
group
[25(OH)D>30ng/mL]
Scheme 1.  A randomization scheme: 52 participants were randomly 
selected to receive either ultraviolet light lamp or placebo
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Bone mineral density measurements
BMD was estimated using dual energy X-ray absorptiom-
etry (DEXA, Lunar Radiation Corp, Madison, Wisconsin) 
before, and 8 and 12 weeks after treatment. All lumbar 
vertebrae and hips were measured.
Statistical analysis
Biochemical markers before treatment and 4, 8, and 12 
weeks after treatment, and biomechanical markers before 
treatment, and 8 and 12 weeks after treatment in each 
group were analysed with repeated-measure two-factor 
analysis. All data were referred to as mean ± standard er-
ror (SE).
The statistical package SPSS for Windows ver. 14.0 was 
used for the analysis. The level of statistical significance 
was set at p-value less than 0.05.
RESULTS
The demographic and baseline characteristics of the popu-
lation were shown in Table 1. There were no significant 
differences between the UVB irradiation group and the 
control group in baseline characteristics.
Biochemical bone markers
Changes of bone specific ALP (bone ALP): No statisti-
cal significance was found in either percentage change or 
results of the quantitative analysis between two groups 
(p>0.05) (Graph 1A).
Changes of the serum 25 hydroxy-vitamin D3 [25 (OH)
D3]: At weeks 4 and 8 after the UVB irradiation, the serum 
level of 25 (OH)D3 in the UVB group was significantly 
increased compared with the controls. Particularly, at 4 
weeks after the UVB irradiation, the mean(±SE) of the 
UVB group was 1.07 (±0.06)%, which was significantly 
higher than that of the control group, 0.85 (±0.06)%. 
There was a statistically significant difference between two 
groups in the change of the serum 25 (OH)D3 level from 
the baseline (p<0.05) (Graph 1B).
Changes of the serum calcium level: There was no sta-
tistically significant difference between these two groups 
in values of the serum calcium level (p>0.05) (Graph 1C).
Changes of the serum C-terminal PTH (PTH-C) level: 
There was no statistically significant difference between 
two groups in changes of the serum PTH-C level over time 
(p>0.05) (Graph 1D).
Changes of the serum osteocalcin (OC) level: There was 
no statistically significant difference between two groups 
in changes of the serum OC level over time (p>0.05) 
(Graph 1E).
Changes of the serum C-terminal telopeptide of type I 
collagen (CTX): There was no statistically significant dif-
ference between two groups in change of the serum CTX 
level over time (p>0.05) (Graph 1F).
Bone mineral density
Lumbar vertebrae: There was no statistically significant 
difference between two groups in terms of percent changes 
over time (p>0.05) (Graph 1G).
Femur: At 8 weeks after the UVB irradiation, the per-
cent change of BMD of the proximal femur in the experi-
mental group was 1.03 (±0.04)%, which was slightly higher 
than in the controls, 0.97 (±0.04)%. However, there was no 
statistically significant difference between two groups in 
percent changes of BMD of the proximal femur over time 
(p>0.05) (Graph 1H).
Subgroup analysis
Based on published studies [7, 8], the subjects in the ex-
periment group (UVB group) were divided into two sub-
groups: if the initial serum 25(OH)D3 level was below 30 
ng/mL, the subject was assigned to the vitamin D insuf-
ficient group (n=8); and if the level was above 30 ng/mL, 
the subject was assigned to the vitamin D normal group 
(n=16).
Biochemical bone markers: The vitamin D insuffi-
cient group showed statistically significant increment in 
serum levels in the 25(OH)D3 compared with the vita-
min D normal group. Serum 25(OH)D3 was significantly 
higher in the insufficient group than in the normal group. 
Table 1. Baseline demographic characteristics of the population: 
Characteristic Experimental group Placebo group
Age (years) 69.20 (3.94) 68.58 (4.43)
Lumbar spine bone mineral density score -2.39 (0.57) -2.26 (0.71)
Femur bone mineral density score -1.22 (0.65) -1.40 (0.85)
Serum calcium (mg/dL) 9.47 (0.51) 9.44 (0.37)
Bone specific alkaline phosphatase (U/L) 30.21 (11.10) 28.02 (9.42)
C-terminal telopeptide of type I collagen (ng/mL) 0.27 (0.19) 0.31 (0.25)
Hydroxy-vitamin D (ng/mL) 43.83 (20.52) 38.60 (15.55)
Osteocalcin (ng/mL) 13.39 (8.44) 13.68 (5.58)
C-terminal parathyroid hormone (ng/ml) 0.34 (0.14) 0.33 (0.12)
Data are mean (SD) unless otherwise specified. All women were Korean, and the mean age was 68.9 years.  
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Graphs 1A-H. Percentage changes of biochemical bone markers and bone mineral density between the UVB group and the controls
After the UVB irradiation, 25(OH)D level was significantly higher in the UVB group than that of the control group (p<0.05) (Graph B). However, other bone formation 
markers did not show any  significant difference between two groups (p>0.05).
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It was 1.56 (±0.08)% at 4 weeks in the insufficient group 
compared to 0.85 (±0.06)% in the normal group. At 12 
weeks, it was 1.41 (±0.10)% in the insufficient group and 
it was 0.79 (±0.07)% in the normal group. There was a 
statistically significant difference between two groups at 
12 weeks (p<0.05) (Graph 2B). The percent change of the 
serum bone ALP level was 0.99 (±0.05)% in the vitamin 
D insufficient group, which was slightly higher than in the 
normal group, 0.87 (±0.03)% at 4 weeks after irradiation. 
Particularly, at 8 weeks, the percent change of bone ALP 
was higher in the vitamin D deficient group, 0.97 (±0.06)% 
than in the normal group, 0.87 (±0.04)%. The bone ALP 
was higher in the vitamin D insufficient group than in 
the normal group, but there was not statistically signifi-
cant difference between two groups (p=0.16) (Graph 2A). 
However, other bone formation markers did not show any 
statistically significant difference between these two groups 
(p>0.05) (Graphs 2A-H).
BMD study: There was no statistically significant differ-
ence in BMD (p>0.05) (Graphs 2G and 2H).
There were no recorded adverse events during the study 
period.
DISCUSSION
Traditional UVB phototherapy with high intensity of illu-
mination (about 20W) was mainly used for skin disorders 
such as psoriasis, atopic dermatitis and vitiligo [12, 13]. 
However, this high- intensity UVB can cause adverse effect 
such as skin cancer and cataract [14]. This study used low 
illumination intensity UVB device (2.62W). When the dis-
tance between lamp and bed reached 100 cm, it dropped to 
4.0-5.0 μw/cm2, and could result in adverse effect. Recently, 
Cicarma et al. [15] have reported the effect of low-dose 
UVB treatment; however, there have been few randomized 
controlled studies investigating the effect of low energy 
UVB treatment on patients with the postmenopausal os-
teoporosis.
One of the most important causes of osteoporosis in 
the elderly population is vitamin D deficiency, which is 
essential for normal calcium and bone metabolism [16]. 
The main source of Vitamin D is sunlight exposure, but a 
number of factors, such as latitude, season, time of day and 
use of topical sunscreen influence the cutaneous produc-
tion of vitamin D [6, 17].
In Korea, despite of the presence of abundant sunlight, 
Yoon et al. [18] reported potential vitamin D deficiency 
and its related bone diseases in menopausal women. The 
percentage of women with serum level of 25(OH)D below 
12 ng/ml was 57.2% (out of a total of 276 women). Roy et 
al. [19] wrote that a number of South Asians had symptoms 
of vitamin D deficiency; and, in particular, individuals with 
the values below 15 ng/ml presented with the increased 
PTH and decreased BMD. Another study reported a cor-
relation between vitamin D, calcium supply and secondary 
hyperthyroid condition [8, 9, 20]. They reported that serum 
calcium and phosphate were significantly higher in vitamin 
D and calcium intake group than in the placebo group.
There are two types of vitamin D production in vivo: 
approximately 10% of vitamin D requirement derives from 
food intake; more than 90% of vitamin D requirement is 
from exposure to sunlight [21]. With age, the vitamin D 
demand is being increased. However, elderly women can 
produce only one-third of vitamin D as compared to young 
women [6, 7, 10]. Holick [17] reported that 295-300 nm of 
the artificial UVB radiation accelerated vitamin D forma-
tion in the skin. The advantage of using UVB was to reduce 
side effects of medication as well as its low cost and easy 
application.
Previous studies reported that exposure of 20% of body 
to either direct sunlight or tanning bed radiation was ef-
fective in increasing the serum vitamin D3 in both young 
and old populations [3, 4, 5, 22]. Indeed, Chuck et al. [4] 
suggested that the use of UVB lamps in nursing homes 
was the most effective method of maintaining the serum 
concentration of 25(OH)D.
This study showed the increased serum level of 25(OH)
D3 in the UVB irradiated group compared to the controls, 
particularly in the vitamin D deficiency subgroup of the 
UVB irradiated group. Bone ALP and Vitamin D were also 
increased significantly compared to the control group.
This study analyzed the effect of low energy UVB on 
bone turnover markers and change of BMD in postmeno-
pausal osteoporotic women for 12 weeks after the treatment 
period. The bone ALP and other bone formation markers 
were slightly higher in the experimental group but there was 
no significant difference during the first four weeks.
When the skin is exposed to UVB with the wavelength 
between 219 and 315 nm, 7-dehydrocholesterol in the 
dermal layer is activated and converted to previtamin D3. 
Pre-vitamin D3 then spontaneously isomerizes to cholecal-
ciferol (vitamin D3) and subsequently it undergoes sequen-
tial hydroxylation to calcifediol (25(OH)D3) in the liver 
and calcitriol (1,25 (OH)2D3) in the kidney, which is the 
major circulating form and the best indicator of vitamin D 
because of its short half-life [17, 23]. In this study, a sharp 
increase in 25(OH)D3 was observed in the experimental 
group, which was statistically significant. Especially, when 
the results were compared between the baseline and post-
irradiation at 4 weeks using the two-sample t-test, the re-
sponse was higher in the UVB group (45%) than in the 
controls (16%).
The PTH secretion was activated by low serum calcium 
rate, and it appeared that the higher serum PTH rate, the 
faster bone turnover rate. In a recent study, the PTH-C 
synthesized in the thyroid yielded five times higher level in 
circulation than intact PTH. It was cleared predominantly 
through the kidneys compared to intact PTH, which was 
cleared through the liver and kidneys [24]. Accordingly, if 
there were renal problems, PTH-C would be higher in the 
blood and take part in bone physiological activation [25]. 
In this study, there was little change in serum PTH-C and 
calcium over 12 weeks. This could be owing to homeos-
tasis of the calcium as a normal body mechanism, and we 
expected no side effects from overdose or deficit serum 
calcium. There were no statistically significant differences 
in OC, the bone turnover marker, CTX and BMD.  
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Graphs 2A-H. Percentage changes of biochemical bone markers and bone mineral density between the vitamin D normal group and the 
vitamin D insufficient group
If the subject's initial serum 25(OH)D level was below 30 ng/mL, the subject was assigned to the vitamin D insufficient group; if the subject's 25(OH)D level was 
above 30 ng/mL, the subject was assigned to the vitamin D normal group. The 25(OH)D level was significantly higher in vitamin D insufficient group than that of 
the normal group (p<0.05) (Graph B).
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In our study, the treatment group was further divided 
into two, based on definition of the vitamin D insufficient 
group as the condition below or equal 30ng/mL vitamin 
D and the normal group as higher than 30ng/mL vitamin 
D [3, 4, 26, 27]. However, it is still controversial to de-
fine a deficiency of vitamin D. Heaney et al. [9] reported 
relationship between vitamin D and calcium absorption. 
They reported that calcium absorption rate was sharply 
decreased in 50.1 to 86.5 nmol/L range of vitamin D. In 
another study, the relationship between serum PTH and 
25(OH)D required at least 72 nmol/L vitamin D which did 
not induce secondary hyperthyroidism [28, 29]. According 
to Lips’ study [29], serum PTH level would start to increase 
when 25(OH)D was between 30 and 78 nmol/L, however, 
this was also affected by many factors such as serum cal-
cium level. They concluded that the appropriate range for 
serum 25(OH)D was 50 nmol/ L.
The OC is the most important bone specific noncolla-
gen protein and is also called Bone gla protein (BGP). It is 
dependent on vitamin K, which is stimulated by vitamin D 
and secreted by osteoblasts. Then, it circulates in the blood 
or is absorbed into the bone matrix. Therefore, it can be 
used as the bone turnover index [30]. In this study, the OC 
increased in post-irradiation weeks 4 and 8 in the vitamin 
D insufficient group, but there was no significant difference.
A calcium and vitamin D supplement is effective for 
preventing osteoporosis. Toss et al. [31] reported the role 
of UVB radiation in vitamin D deficiency groups. They di-
vided elderly people into three groups: 1) the oral vitamin D 
and calcium intake group, 2) the calcium intake group, and 
3) the UVB radiation group. UVB radiation was performed 
once a week for 3 months. The other groups took 450 IU 
vitamin D2 and 420 g calcium. They reported higher serum 
25(OH)D in the UVB group and vitamin D and calcium 
intake group. Bone ALP was decreased in the vitamin D and 
calcium intake group. They reported that UVB radiation 
was an effective and safe method for preventing the lack 
of vitamin D, but it was time-consuming.Meier et al. [32] 
reported the effects of vitamin D and calcium supply on 
prevention of bone loss due to seasonal variation in healthy 
adults. They showed the increments of BMD and vitamin D 
in the vitamin D deficient group compared to the controls. 
However, in this study, we noted little change in BMD in 
this elderly population.
A limitation of this study is that the effect of UVB was 
tested without control of the outdoor activities and diet. 
Further, this clinical trial was conducted over a limited 
period of two weeks. Comparing to our previous animal 
pilot study, it has been noted that even two weeks of UVB 
irradiation is sufficient to find difference in two groups.
CONCLUSION
In summary, UVB radiation (wavelengths between 280 and 
400 nm) 30 minutes a day for two weeks added no skeletal 
benefit in postmenopausal women with osteoporosis dur-
ing 8 weeks when assessed with BMD. However, vitamin 
D was increased significantly in subjects in the vitamin D 
insufficient group. These findings may signify the future 
application of UVB irradiation for the increase of serum 
vitamin D in the elderly with vitamin D insufficiency. 
However, a long-term study in a larger patient group is 
required to demonstrate clinical significance and confirm 
this finding.
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КРАТАК САДРЖАЈ
Увод Зна  чај ви  та  ми  на Д на гу  сти  ну ко  сти и осте  о  по  ро  зу ис-
пи  ти  ва  ли су мно  ги ис  тра  жи  ва  чи. Глав  на уло  га ви  та  ми  на Д 
огле  да се у ап  сорп  ци  ји кал  ци  ју  ма и фос  фа  та и по  ве  ћа  њу 
ко  шта  не ми  не  ра  ли  за  ци  је. Код ста  рих љу  ди је сла  би  ја про-
из  вод  ња ви  та  ми  на Д у ко  жи због сла  бе из  ло  же  но  сти сун  цу 
и сма  ње  њу мо  гућ  но  сти ко  же за син  те  зу.
Циљ ра  да Циљ ове кли  нич  ке сту  ди  је био је да се утвр  де 
ефи  ка  сност и под  но  шљи  вост крат  ко  трај  ног деј  ства (две не-
де  ље) ни  ско  е  нер  гет  ског ул  тра  љу  би  ча  стог (UVB) зра  че  ња 
код же  на с осте  о  по  ро  зом у пост  ме  но  па  у  зи ме  ре  њем ми-
не  рал  не гу  сти  не ко  сти и мар  ке  ра ко  шта  ног ме  та  бо  ли  зма.
Ме  то  де ра  да Тро  ме  сеч  на, сле  па, ран  до  ми  зи  ра  на, пла  це  бо-
кон  трол  на кли  нич  ка сту  ди  ја ура  ђе  на је у Уни  вер  зи  тет  ској 
бол  ни  ци у Де  гуу, у Ју  жној Ко  ре  ји. Пе  де  сет и две же  не с пост-
ме  но  па  у  зном осте  о  по  ро  зом (ста  ри  је од 65 го  ди  на) на  су  мич-
но су под  врг  ну  те деј  ству ни  ско  е  нер  гет  ског UVB зра  че  ња или 
пла  це  бо ефек  ту у тра  ја  њу од 30 ми  ну  та то  ком две не  де  ље, 
у зим  ским ме  се  ци  ма. Кли  нич  ки и ла  бо  ра  то  риј  ски пре  гле  ди 
ра  ђе  ни су пре из  ла  га  ња зра  че  њу, а по  том че  ти  ри не  де  ље, 
осам и 12 не  де  ља на  кон зра  че  ња. Ми  не  рал  на гу  сти  на ко  сти 
ме  ре  на је пре, а за  тим осам и 12 не  де  ље по  сле зра  че  ња.
Ре  зул  та  ти По  ка  зан је ути  цај UVB зра  че  ња на ви  та  мин Д 
и ни  во ко  шта  не ал  кал  не фос  фа  та  зе (ALP) код же  на са ин-
су  фи  ци  јен  ци  јом ви  та  ми  на Д, као и по  зи  тив  ни ефе  кат на 
струк  ту  ру ко  сти. У гру  пи ис  пи  та  ни  ца са ин  су  фи  ци  јен  ци  јом 
ви  та  ми  на Д уоче  на је ста  ти  стич  ки зна  чај  на раз  ли  ка у по  ве-
ћа  њу 25(OH)D3 у од  но  су на гру  пу ко  ја је при  ма  ла пла  це  бо 
(p<0,5). Ме  ђу  тим, ни  је би  ло ста  ти  стич  ки зна  чај  не раз  ли  ке 
из  ме  ђу две гру  пе у по  гле  ду дру  гих по  ка  за  те  ља ко  шта  ног 
ме  та  бо  ли  зма (Ca, PTH-C, осте  о  кал  цин у се  ру  му, се  рум CTX) 
и ми  не  рал  ну гу  сти  ну ко  сти.
За  кљу  чак Крат  ко  трај  но из  ла  га  ње ни  ско  е  нер  гет  ском UVB 
зра  че  њу же  на у пост  ме  но  па  у  зи ко  је бо  лу  ју од осте  о  по  ро-
зе мо  же би  ти ко  ри  сно у син  те  зи ви  та  ми  на Д, али је уоче  но 
ма  ло по  бољ  ша  ње у из  ме  ни ALP, по  го  то  во код же  на са ин-
су  фи  ци  јен  ци  јом ви  та  ми  на Д.
Кључ  не ре  чи: ни  ско  е  нер  гет  ско ул  тра  љу  би  ча  сто зра  че  ње; 
осте  о  по  ро  за; ми  не  рал  на гу  сти  на ко  сти; мар  кер ко  шта  ног 
ме  та  бо  ли  зма
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